Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine development

Deirdre F Foley, Timothy K Chege, Joyce Kabagenyi, Karen McCarthy, Elijah T Gicheru, Nelson Kibinge, Angela W Maina, Jacqueline M Waeni, Ralf Clemens, Sue-Ann Costa Clemens, James Tuju, Charles J Sande
doi: https://doi.org/10.1101/2024.01.10.24300883
Deirdre F Foley
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
2Department of Continuing Education, University of Oxford, Oxford, UK
3Children’s Health Ireland – Crumlin, Dublin, Ireland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: deirdrefoley731{at}gmail.com csande{at}kemri-wellcome.org
Timothy K Chege
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
4Institute of Global Health, University of Siena, Siena, Italy
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Kabagenyi
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen McCarthy
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
2Department of Continuing Education, University of Oxford, Oxford, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elijah T Gicheru
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Dip
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelson Kibinge
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela W Maina
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline M Waeni
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Clemens
5International Vaccine Institute, Seoul, Republic of Korea
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue-Ann Costa Clemens
4Institute of Global Health, University of Siena, Siena, Italy
6Oxford Vaccine Group, University of Oxford, Oxford, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Tuju
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles J Sande
1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
7Nuffield Department of Medicine, University of Oxford, Oxford, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: deirdrefoley731{at}gmail.com csande{at}kemri-wellcome.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The paucity of data on the contemporary causes of serious infection among the world’s most vulnerable children means the landscape of emerging paediatric infectious disease remains largely undefined and out of focus on the global vaccine research and development agenda.

Methods We aimed to partially define the paediatric infectious disease landscape in a typical low-income setting in sub-Saharan Africa in Kilifi, Kenya by simultaneously estimating antibody prevalence for 38 infectious diseases using a longitudinal birth cohort that was sampled between 2002 and 2008 and a paediatric inpatient cohort that was sampled between 2006 and 2017.

Findings Among the infectious diseases with the highest antibody prevalence in the first year of life were vaccine-preventable diseases such as RSV (57.4%), mumps (31.5%) and influenza H3N2 (37.3%). Antibody prevalence for Plasmodium falciparum shifted substantially over time, from 47% in the mid 2000s to 13% approximately 10 years later corresponding to a documented decline in parasite transmission. A high prevalence of antibodies was also observed in the first year of life for infections for which no licenced vaccines are currently available, including norovirus (34.2%), cytomegalovirus (44.7%), EBV (29.3%) and coxsackie B virus (40.7%). The prevalence to antibodies to vaccine antigens in the local immunisation schedule was generally high but varied by antigen.

Interpretation The data show a high and temporally stable infection burden of RSV, mumps and influenza, providing a compelling evidence base to support progress towards the introduction of these vaccines into the local immunization schedule. The high prevalence of norovirus, EBV, CMV and Coxsackie B provide rationale for increased vaccine research and development investment.

Funding This research was funded by the Wellcome Trust (grant no. WT105882MA).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Wellcome Trust

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Scientific Ethics Research Unit of the Kenya Medical Research Institute gave ethical approval for this work. The parents and legal representatives of all the children in this study provided written informed consent prior to recruitment into the study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 10, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine development
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine development
Deirdre F Foley, Timothy K Chege, Joyce Kabagenyi, Karen McCarthy, Elijah T Gicheru, Nelson Kibinge, Angela W Maina, Jacqueline M Waeni, Ralf Clemens, Sue-Ann Costa Clemens, James Tuju, Charles J Sande
medRxiv 2024.01.10.24300883; doi: https://doi.org/10.1101/2024.01.10.24300883
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine development
Deirdre F Foley, Timothy K Chege, Joyce Kabagenyi, Karen McCarthy, Elijah T Gicheru, Nelson Kibinge, Angela W Maina, Jacqueline M Waeni, Ralf Clemens, Sue-Ann Costa Clemens, James Tuju, Charles J Sande
medRxiv 2024.01.10.24300883; doi: https://doi.org/10.1101/2024.01.10.24300883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (433)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3308)
  • Dentistry and Oral Medicine (365)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1174)
  • Epidemiology (13391)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5168)
  • Geriatric Medicine (482)
  • Health Economics (784)
  • Health Informatics (3282)
  • Health Policy (1144)
  • Health Systems and Quality Improvement (1197)
  • Hematology (432)
  • HIV/AIDS (1021)
  • Infectious Diseases (except HIV/AIDS) (14648)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4941)
  • Nursing (262)
  • Nutrition (733)
  • Obstetrics and Gynecology (887)
  • Occupational and Environmental Health (796)
  • Oncology (2527)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (546)
  • Pediatrics (1304)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4221)
  • Public and Global Health (7522)
  • Radiology and Imaging (1710)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (499)
  • Sports Medicine (425)
  • Surgery (550)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (206)